Staff Profile

I an currently a Research Associate working within the REACH (Researching Equity, Access and Cancer Health Outcomes) team. My research currently focusses on oral medication adherence in cancer patients and risk factors in the development of cancer. I am involved with a range of cancer trials but also use NHS and real world data to explore these topics.

Previously I have explored how residual beta-cell function in individuals with type 1 diabetes influences glucose control at rest and around exercise, as well on the vascular benefits of exercise. I have been lucky to be involved with exercise and nutrition research in a range of clinical and healthy populations including; type 2 diabetes, non-alcoholic fatty liver disease, heart failure, mitochondrial disease, obesity, and professional athletes.  

Expertise

I am currently focussed on big health data analytics. I have previously completed exercise and physiology projects involving exercise testing high-risk patient groups, phlebotomy and cannulation, ECG placement and interpretation, sample handling and analysis, continuous glucose monitoring data and quantifying rare cells in the blood by flow cytometry.

Qualifications

PhD Clinical Exercise Physiology - Newcastle University

American College of Sports Medicine Certified Clinical Exercise Physiologist

MSc Clinical Exercise Physiology - Northumbria University

BSc Applied Sport and Exercise Science - Northumbria University

My research currently focusses on oral medication adherence in cancer patients and risk factors in the development of cancer.

• Articles

  • McGeagh L, Stewart S-J, Norris R, Wells M, Thompson S, Mawson P, Brett J, Turner M, Wolstenholme J, Dakin H, Donnelly P, Cain H, Rehman F, Kum S, Horne R, Taylor G, Turner L, Rose J, Sharp L, Watson E. Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention. European Journal of Oncology Nursing 2026, 80, epub ahead of print.
  • Taylor G, Burger B, Scragg JH, Page O, Schmid H, Nsengimana J, West DJ, Shaw JA. Impact of Age at diagnosis and insulin delivery modality on free-living glycemia in Type 1 diabetes during periods associated with dysglycemia: a retrospective analysis of the type 1 diabetes exercise initiative study. Diabetes technology and therapeutics 2025, 27(11), 907-918.
  • Reid A, Sibbering L, Burridge I, Kalra L, Critchley A, Thomas R, Pieri A, Carter J, O'Donoghue JM, Taylor G, Fairhurst K, Cain H. Chest wall perforator flaps for partial breast reconstruction: An observational cohort study of 290 women to evaluate clinical and oncological outcomes. European Journal of Surgical Oncology 2025, 51(11), 110430.
  • Taylor GS, Smith K, Scragg J, McDonald TJ, Shaw JA, West DJ, Roberts LD. The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes. Diabetologia 2024, 67, 413–1428.
  • Smith K, Taylor GS, Peeters W, Walker M, Perazzolo S, Atabaki-Pasdar N, Bowden Davies KA, Karpe F, Hodson L, Stevenson EJ, West DJ. Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes. Diabetologia 2024, 67, 2555-2567.
  • Stocker R, Gupta A, Taylor GS, Shaw JA, West DJ. Adapting to compromised routines: Parental perspectives on physical activity and health for children and adolescents with type 1 diabetes in the UK during COVID-19 lockdown. Journal of Pediatric Nursing 2024, 77, e242-e250.
  • Karsdal MA, Hallsworth K, Scragg J, Leeming DJ, Villesen IF, Avery L, Haigh L, Govaere O, Wichmann S, Taylor G, Cassidy S, McPherson S, Anstee QM. Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease. Hepatology Communications 2023, 7(10), e0254.
  • Taylor GS, Shaw A, Scragg JH, Smith K, Campbell MD, Macdonald TJ, Shaw JAM, Ross MD, West DJ. Type 1 diabetes patients with different residual beta-cell function but similar age, HBA1c, and cardiorespiratory fitness have differing exercise-induced angiogenic cell mobilisation. Frontiers in Endocrinology: Clinical Diabetes 2022, 13, 797438.
  • Smith K, Taylor GS, Brunsgaard LH, Walker M, Bowden KA, Stevenson EJ, West DJ. Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes. BMJ Open Diabetes Research & Care 2022, 10(3), e002820.
  • Smith K, Taylor GS, Brunsgaard LH, Walker M, Bowden KA, Stevenson EJ, West DJ. Pre-Meal Whey Protein Alters Postprandial Insulinemia by Enhancing β-Cell Function and Reducing Insulin Clearance in T2D. The Journal of Clinical Endocrinology & Metabolism 2022, 108(8), e603–e612.
  • Capper TE, Siervo M, Clifford T, Taylor G, Iqbal W, West D, Stevenson EJ. Pharmacokinetic Profile of Incremental Oral Doses of Dietary Nitrate in Young and Older Adults: A Crossover Randomized Clinical Trial. The Journal of Nutrition 2022, 152(1), 130-139.
  • Taylor GS, Shaw AC, Smith K, Wason J, McDonald TJ, Oram RA, Stevenson E, Shaw JAM, West DJ. Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes. Diabetic Medicine 2022, 39(5), e14814.
  • Taylor GS, Shaw A, Smith K, Capper TE, Scragg JH, Cronin M, Bashir A, Flatt A, Campbell MD, Stevenson EJ, Shaw JA, Ross M, West DJ. Type 1 diabetes patients increase CXCR4+ and CXCR7+ haematopoietic and endothelial progenitor cells with exercise, but the response is attenuated. Scientific Reports 2021, 11(1), 14502.
  • Smith K, Taylor GS, Allerton DM, Brunsgaard LH, Bowden Davies KA, Stevenson EJ, West DJ. The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial. Frontiers in Endocrinology 2021, 12, 696977.
  • Stocker R, Shaw JA, Taylor GS, Witham MD, West DJ. EXercise to Prevent frailty and Loss Of independence in insulin treated older people with DiabetEs (EXPLODE): protocol for a feasibility randomised controlled trial (RCT). BMJ Open 2021, 11, e048932.
  • Taylor GS, Smith K, Capper TE, Scragg JH, Bashir A, Flatt A, Stevenson EJ, McDonald TJ, Oram RA, Shaw JA, West DJ. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function. Diabetes Care 2020, 43(10), 2362-2370.
  • Scragg J, Avery L, Cassidy S, Taylor G, Haigh L, Boyle M, Trenell MI, Anstee QM, McPherson S, Hallsworth K. Feasibility of a very low calorie diet to achieve a sustainable 10% weight loss in patients with non-alcoholic fatty liver disease. Clinical and Translational Gastroenterology 2020, 11(9), e00231.
  • Taylor GS, Moser O, Smith K, Shaw A, Tang JCY, Fraser WD, Eckstein ML, Aziz F, Stevenson EJ, Shaw JA, West DJ. Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case-control study. BMJ Open Diabetes Research and Care 2020, 8(2), e001779.

• Conference Proceedings (inc. Abstract)

  • Page O, Carruthers M, Taylor GS, Orange ST, Dulson DK, West DJ, Jeffries O. Accuracy of Dexcom G7 and Freestyle Libre 2 during acute exposure to hot, dry conditions in healthy adults. In: Diabetes UK Professional Conference 2025. 2025, Glasgow, UK: Wiley-Blackwell Publishing Ltd.

• Letter

  • Scragg J, Charman SJ, van Hees VT, Avery L, Taylor GS, Anstee QM, McPherson S, Cassidy S, Hallsworth K. Physical Activity, Inactivity and Sleep in Patients with Significant Non-Alcoholic Fatty Liver Disease. American Journal of the Medical Sciences 2022, 363(1), 80-83.